Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group.

OBJECTIVE The Osteoarthritis Research Society International initiated a number of working groups to address a call from the US Food and Drug Administration (FDA) on updating draft guidance on conduct of osteoarthritis (OA) clinical trials. The development of disease-modifying osteoarthritis drugs (DMOADs) remains challenging. The Assessment of Structural Change (ASC) Working Group aimed to provide a state-of-the-art critical update on imaging tools for OA clinical trials. METHODS The Group focussed on the performance metrics of conventional radiographs (CR) and magnetic resonance imaging (MRI), performing systematic literature reviews for these modalities. After acquiring these reviews, summary and research recommendations were developed through a consensus process. RESULTS For CR, there is some evidence for construct and predictive validity, with good evidence for reliability and responsiveness of metric measurement of joint space width (JSW). Trials off at least 1 and probably 2 years duration will be required. Although there is much less evidence for hip JSW, it may provide greater responsiveness than knee JSW. For MRI cartilage morphometry in knee OA, there is some evidence for construct and predictive validity, with good evidence for reliability and responsiveness. The responsiveness of semi-quantitative MRI assessment of cartilage morphology, bone marrow lesions and synovitis was also good in knee OA. CONCLUSIONS Radiographic JSW is still a recommended option for trials of structure modification, with the understanding that the construct represents a number of pathologies and trial duration may be long. MRI is now recommended for clinical trials in terms of cartilage morphology assessment. It is important to study all the joint tissues of the OA joint and the literature is growing on MRI quantification (and its responsiveness) of non-cartilage features. The research recommendations provided will focus researchers on important issues such as determining how structural change within the relatively short duration of a trial reflects long-term change in patient-centred outcomes.

[1]  Felix Eckstein,et al.  Radiologic markers of osteoarthritis progression , 2009, Current opinion in rheumatology.

[2]  M-P. Hellio Le Graverand-Gastineau.  OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? , 2009 .

[3]  D J Hunter,et al.  Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. , 2011, Osteoarthritis and cartilage.

[4]  I. Ackerman,et al.  Variation in age and physical status prior to total knee and hip replacement surgery: a comparison of centers in Australia and Europe. , 2009, Arthritis and rheumatism.

[5]  Philip G Conaghan,et al.  Imaging the painful osteoarthritic knee joint: what have we learned? , 2009, Nature Clinical Practice Rheumatology.

[6]  K. Brandt,et al.  Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis. , 1999, Rheumatic diseases clinics of North America.

[7]  T. Spector,et al.  Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. , 2006, Arthritis and rheumatism.

[8]  L. Sharma,et al.  Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. , 2005, Arthritis and rheumatism.

[9]  P A Dieppe,et al.  Yet more evidence that osteoarthritis is not a cartilage disease , 2006, Annals of the rheumatic diseases.

[10]  D. J. Hunter,et al.  Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. , 2011, Osteoarthritis and cartilage.

[11]  G. Hawker.  Who, when, and why total joint replacement surgery? The patient's perspective , 2006, Current opinion in rheumatology.

[12]  E. Losina,et al.  Responsiveness and reliability of MRI in knee osteoarthritis: a meta-analysis of published evidence. , 2011, Osteoarthritis and cartilage.

[13]  E. Losina,et al.  Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic review. , 2011, Osteoarthritis and cartilage.

[14]  K. Brandt,et al.  Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs. , 2005, Arthritis and rheumatism.

[15]  H. Keen,et al.  A systematic review of ultrasonography in osteoarthritis , 2009, Annals of the rheumatic diseases.

[16]  Ali Guermazi,et al.  The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. , 2005, Arthritis and rheumatism.

[17]  A Guermazi,et al.  Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? , 2006, Arthritis and rheumatism.

[18]  David Felson,et al.  Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies , 2009, BMJ : British Medical Journal.

[19]  Felix Eckstein,et al.  Imaging in osteoarthritis. , 2008, Rheumatic diseases clinics of North America.